Werewolf Therapeutics (HOWL) Receivables - Other (2022 - 2024)
Werewolf Therapeutics (HOWL) posted quarterly Receivables - Other of -$464000.0 for Q4 2024, up 89.83% year-over-year from -$244433.4 in Q1 2024, and down 200.0% on a QoQ basis from $464000.0 in Q3 2024.
Werewolf Therapeutics (HOWL) Receivables - Other (2022 - 2024) Analysis & Trends
Werewolf Therapeutics has reported Receivables - Other for 3 years, with the latest figure at -$464000.0 in Q4 2024.
- Receivables - Other for Q4 2024 came in at -$464000.0, up 89.83% year-over-year; the trailing twelve-month figure through Sep 2025 was -$464000.0 (down 200.0% YoY), and the FY2024 annual result was -$1.3 million, up 75.8% from the prior year.
- Receivables - Other eased to -$464000.0 in Q4 2024, from $464000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $6.9 million in Q4 2022 and troughed at -$4.6 million in Q4 2023.
- A 3-year average of $2.5 million and a median of $2.1 million in 2022 frame the typical range for Receivables - Other.
- The largest YoY upside for Receivables - Other was 212.03% in 2023 against a maximum downside of 165.83% in 2023.
- A 3-year view of Receivables - Other shows it stood at $6.9 million in 2022, then plunged by 165.83% to -$4.6 million in 2023, then jumped by 89.83% to -$464000.0 in 2024.
- Per Business Quant data, the three most recent Receivables - Other figures were -$464000.0 in Q4 2024, $464000.0 in Q3 2024, and $545000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -464,000.00 |
| Dec 31, 2024 | -464,000.00 |
| Sep 30, 2024 | 464,000.00 |
| Sep 30, 2024 | 464,000.00 |
| Jun 30, 2024 | 545,000.00 |
| Jun 30, 2024 | 545,000.00 |
| Mar 31, 2024 | 775,000.00 |
| Mar 31, 2024 | 775,000.00 |
| Dec 31, 2023 | -4.56 Mn |
| Dec 31, 2023 | -4.56 Mn |
| Sep 30, 2023 | 5.91 Mn |
| Sep 30, 2023 | 5.91 Mn |
| Jun 30, 2023 | 6.93 Mn |
| Jun 30, 2023 | 6.93 Mn |
| Mar 31, 2023 | 6.26 Mn |
| Mar 31, 2023 | 6.26 Mn |
| Dec 31, 2022 | 6.93 Mn |
| Dec 31, 2022 | 6.93 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Sep 30, 2022 | 2.08 Mn |